Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Hepatitis C

Free Subscription Articles published in Transplant Proc Retrieve available abstracts of 50 articles: HTML format Text format

Single Articles

June 2018
1. PESCHEL G, Moleda L, Baier L, Selgrad M, et al
   Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post-Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response-A Single-Center Study.
   Transplant Proc. 2018;50:1444-1450.
   PubMed     Text format     Abstract available
   
   
   
2. BODRO M, Sanclemente G, Crespo G, Linares L, et al
   Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients.
   Transplant Proc. 2018;50:1437-1443.
   PubMed     Text format     Abstract available
   
   
   
3. WAHAB MA, Shehta A, Elshoubary M, Yassen AM, et al
   Living-Donor Liver Transplantation in Hepatitis C Virus Era: A Report of 500 Consecutive Cases in a Single Center.
   Transplant Proc. 2018;50:1396-1406.
   PubMed     Text format     Abstract available
   
   
   April 2018
4. IMAI H, Kamei H, Onishi Y, Ishizu Y, et al
   Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus.
   Transplant Proc. 2018 Apr 25. pii: S0041-1345(18)30211.
   PubMed     Text format     Abstract available
   
   
   
5. ORUC A, Ersoy A
   Transplantation Opportunities of Hepatitis C Virus-Seropositive Patients on the Kidney Waiting List.
   Transplant Proc. 2018 Apr 18. pii: S0041-1345(18)30614.
   PubMed     Text format     Abstract available
   
   
   
6. TAKEUCHI S, Takamura M, Yoshida T, Takahashi K, et al
   Ombitasvir-Paritaprevir-Ritonavir Therapy in a Kidney Transplant Recipient With Chronic Hepatitis C Virus Genotype 1 Infection: A Case Report on the Importance of Considering Drug-Drug Interactions and Monitoring Cyclosporine Levels.
   Transplant Proc. 2018;50:884-886.
   PubMed     Text format     Abstract available
   
   
   
7. WEIGERT A, Querido S, Carvalho L, Lebre L, et al
   Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal.
   Transplant Proc. 2018;50:743-745.
   PubMed     Text format     Abstract available
   
   
   March 2018
8. NOGUERAS LOPEZ F, Lopez Garrido A, Ortega Suazo EJ, Vadillo Calles F, et al
   Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients.
   Transplant Proc. 2018;50:631-633.
   PubMed     Text format     Abstract available
   
   
   
9. CAICEDO LA, Delgado A, Garcia VH, Aristizabal AM, et al
   Liver Transplantation in Hepatitis C-Infected Patients: Experience From a South American Transplant Center.
   Transplant Proc. 2018;50:493-498.
   PubMed     Text format     Abstract available
   
   
   November 2017
10. TOWNSEND SA, Monga MA, Nightingale P, Mutimer D, et al
    Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
    Transplant Proc. 2017;49:2129-2134.
    PubMed     Text format     Abstract available
    
    
    
11. ROULLET S, Defaye M, Quinart A, Adam JP, et al
    Liver Transplantation With Old Grafts: A Ten-Year Experience.
    Transplant Proc. 2017;49:2135-2143.
    PubMed     Text format     Abstract available
    
    
    October 2017
12. FREY A, Ecker EM, Piras-Straub K, Walker A, et al
    Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
    Transplant Proc. 2017;49:1947-1955.
    PubMed     Text format     Abstract available
    
    
    
13. LIAO HT, Tan P, Huang JW, Yuan KF, et al
    Ledipasvir + Sofosbuvir for Liver Transplant Recipients With Recurrent Hepatitis C: A Systematic Review and Meta-analysis.
    Transplant Proc. 2017;49:1855-1863.
    PubMed     Text format     Abstract available
    
    
    September 2017
14. SHAFII AE, Harris DD 2nd, Baz M
    Clearance of Hepatitis C Virus Prior to Lung Transplantation: A Case Report.
    Transplant Proc. 2017;49:1682-1684.
    PubMed     Text format     Abstract available
    
    
    
15. NAKANO R, Ohira M, Ishiyama K, Ide K, et al
    Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:1634-1638.
    PubMed     Text format     Abstract available
    
    
    July 2017
16. TRONINA O, Slubowska K, Mikolajczyk-Korniak N, Komuda-Leszek E, et al
    Fibrosing Cholestatic Hepatitis C After Liver Transplantation: Therapeutic Options Before and After Introduction of Direct-Acting Antivirals: Our Experience and Literature Review.
    Transplant Proc. 2017;49:1409-1418.
    PubMed     Text format     Abstract available
    
    
    June 2017
17. OHIRA M, Nishida S, Tryphonopoulos P, Ruiz P, et al
    Impact of Steroids on Natural Killer Cells Against Cytotoxicity and Hepatitis C Virus Replication.
    Transplant Proc. 2017;49:1160-1164.
    PubMed     Text format     Abstract available
    
    
    
18. KOSHINO K, Ushigome H, Masuda K, Matsuyama T, et al
    Effective Treatment With Daclatasvir and Asunaprevir in Kidney Transplant Patients Infected With Hepatitis C Virus: A Report of Two Cases.
    Transplant Proc. 2017;49:1053-1055.
    PubMed     Text format     Abstract available
    
    
    May 2017
19. PIAI G, Miglioresi L, Valente G
    Eradication of Hepatitis C After Liver Transplantion: Consequences for the Organization of the Transplant Patient's Follow-up.
    Transplant Proc. 2017;49:671-673.
    PubMed     Text format     Abstract available
    
    
    
20. TRAPANI S, Rizzato L, Masiero L, Ricci A, et al
    Hepatitis C Virus Positive Patients on the Waiting List for Liver Transplantation: Turnover and Characteristics of the Population on the Eve of the Therapeutic Revolution With Direct-Acting Antivirals.
    Transplant Proc. 2017;49:658-666.
    PubMed     Text format     Abstract available
    
    
    January 2017
21. MELLO F, Girao C, Castro CC, Fiuza S, et al
    De Mello's Single Incision for Combined Liver-kidney Transplantation, Keeping the Kidney Retroperitoneal: A Case Report.
    Transplant Proc. 2017;49:169-171.
    PubMed     Text format     Abstract available
    
    
    November 2016
22. DENG G, Ma J, Shen S, Li Q, et al
    Sofosbuvir Monotherapy for Asymptomatic and Noncirrhotic Hepatitis C Infection in a Renal Retransplantation Recipient: A Case Report.
    Transplant Proc. 2016;48:3120-3122.
    PubMed     Text format     Abstract available
    
    
    
23. SANCHEZ ANTOLIN G, Testillano M, Pascasio JM, Narvaez Rodriguez I, et al
    Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort.
    Transplant Proc. 2016;48:3013-3016.
    PubMed     Text format     Abstract available
    
    
    
24. BERGE E, Oton E, Reina Z, Diaz L, et al
    Predictors of Poor Prognosis in Recurrent Hepatitis C After Liver Transplantation.
    Transplant Proc. 2016;48:2997-2999.
    PubMed     Text format     Abstract available
    
    
    
25. GENTIL MA, Gonzalez-Corvillo C, Perello M, Zarraga S, et al
    Hepatitis C Treatment With Direct-Acting Antivirals in Kidney Transplant: Preliminary Results From a Multicenter Study.
    Transplant Proc. 2016;48:2944-2946.
    PubMed     Text format     Abstract available
    
    
    
26. SUAREZ BENJUMEA A, Gonzalez-Corvillo C, Sousa JM, Bernal Blanco G, et al
    Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication.
    Transplant Proc. 2016;48:2938-2940.
    PubMed     Text format     Abstract available
    
    
    
27. GARCIA BERNARDO CM, Arguelles Garcia B, Redondo Buil P, Miyar de Leon A, et al
    Collateral Development in Thrombosis of the Hepatic Artery After Transplantation.
    Transplant Proc. 2016;48:3006-3009.
    PubMed     Text format     Abstract available
    
    
    
28. SAFWAN M, Nagai S, Abouljoud MS
    Portal Vein Inflow From Enlarged Coronary Vein in Liver Transplantation: Surgical Approach and Technical Tips: A Case Report.
    Transplant Proc. 2016;48:3070-3072.
    PubMed     Text format     Abstract available
    
    
    
29. CEPEDA-FRANCO C, Bernal-Bellido C, Barrera-Pulido L, Alamo-Martinez JM, et al
    Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
    Transplant Proc. 2016;48:2983-2986.
    PubMed     Text format     Abstract available
    
    
    October 2016
30. ALDEMIR E, Coskunol H, Kilic M, Sert I, et al
    Treatment of Opioid Dependence With Buprenorphine/Naloxone After Liver Transplantation: Report of Two Cases.
    Transplant Proc. 2016;48:2769-2772.
    PubMed     Text format     Abstract available
    
    
    September 2016
31. BENITEZ-GUTIERREZ L, de Mendoza C, Banos I, Duca A, et al
    Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir.
    Transplant Proc. 2016;48:2515-2518.
    PubMed     Text format     Abstract available
    
    
    June 2016
32. MIKOLAJCZYK-KORNIAK N, Tronina O, Slubowska K, Perkowska-Ptasinska A, et al
    Dynamic Elastography in Diagnostics of Liver Fibrosis in Patients After Liver Transplantation Due to Cirrhosis in the Course of Hepatitis C.
    Transplant Proc. 2016;48:1725-9.
    PubMed     Text format     Abstract available
    
    
    
33. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Transplant Registry in Poland: Web-Netted Quality Tool in Liver Transplantation From Deceased and Living Donors.
    Transplant Proc. 2016;48:1347-9.
    PubMed     Text format     Abstract available
    
    
    
34. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Donation and Transplantation in Poland: Numbers, Indicators, and Trends.
    Transplant Proc. 2016;48:1341-6.
    PubMed     Text format     Abstract available
    
    
    May 2016
35. TANEMURA A, Mizuno S, Kato H, Murata Y, et al
    D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.
    Transplant Proc. 2016;48:1025-31.
    PubMed     Text format     Abstract available
    
    
    
36. ASAVAKARN S, Sirivatanauksorn Y, Promraj R, Ruenrom A, et al
    Systematic Pharmaceutical Educational Approach to Enhance Drug Adherence in Liver Transplant Recipients.
    Transplant Proc. 2016;48:1202-7.
    PubMed     Text format     Abstract available
    
    
    
37. KANG GW, Lee IH, Ahn KS, Kim JD, et al
    One-Year Follow-up of the Changes in Renal Function After Liver Transplantation in Patients Without Chronic Kidney Disease.
    Transplant Proc. 2016;48:1190-3.
    PubMed     Text format     Abstract available
    
    
    April 2016
38. CARPIO R, Pamugas GE, Danguilan R, Que E, et al
    Outcomes of Renal Allograft Recipients With Hepatitis C.
    Transplant Proc. 2016;48:836-9.
    PubMed     Text format     Abstract available
    
    
    March 2016
39. MORABITO V, Grossi P, Lombardini L, Ricci A, et al
    Solid Organ Transplantation in HIV+ Recipients: Italian Experience.
    Transplant Proc. 2016;48:424-30.
    PubMed     Text format     Abstract available
    
    
    
40. FERLA F, Mariani A, di Sandro S, Buscemi V, et al
    Do Older Liver Grafts Have Worse Survival? The Niguarda Experience.
    Transplant Proc. 2016;48:362-5.
    PubMed     Text format     Abstract available
    
    
    January 2016
41. LI Z, Sun F, Hu Z, Xiang J, et al
    New-Onset Diabetes Mellitus in Liver Transplant Recipients With Hepatitis C: Analysis of the National Database.
    Transplant Proc. 2016;48:138-44.
    PubMed     Text format     Abstract available
    
    
    
42. LAM PH, Obirieze AC, Ortega G, Nwokeabia I, et al
    Characterization of Hepatitis B and C Among Liver Transplant Recipients With Hepatocellular Carcinoma: An Analysis of the Nationwide Inpatient Sample Database.
    Transplant Proc. 2016;48:123-7.
    PubMed     Text format     Abstract available
    
    
    December 2015
43. MIYAAKI H, Ichikawa T, Taura N, Miuma S, et al
    Impact of Donor and Recipient Single Nucleotide Polymorphisms in Living Liver Donor Transplantation for Hepatitis C.
    Transplant Proc. 2015;47:2916-9.
    PubMed     Text format     Abstract available
    
    
    November 2015
44. SUAREZ-BENJUMEA A, Gonzalez-Corvillo C, Bernal-Blanco G, Pascasio-Acevedo JM, et al
    New Antivirals for Hepatitis C Infection Among Infected Kidney Transplant Recipients: A Case Report.
    Transplant Proc. 2015;47:2672-4.
    PubMed     Text format     Abstract available
    
    
    September 2015
45. TRAKROO S, Qureshi K
    Successful Treatment of Chronic Hepatitis C Infection With Direct-Acting Antivirals in a Heart Transplant Recipient: A Case Report.
    Transplant Proc. 2015;47:2295-7.
    PubMed     Text format     Abstract available
    
    
    
46. GAMAN G, Sarvary E, Gelley F, Doros A, et al
    Analysis of Incretin Hormones After Orthotopic Liver Transplantation.
    Transplant Proc. 2015;47:2207-9.
    PubMed     Text format     Abstract available
    
    
    May 2015
47. ELSIESY H, Abaalkhail F, Al Sebayel M, Broering D, et al
    Spontaneous clearance of hepatitis C genotype 4 after liver retransplantation.
    Transplant Proc. 2015;47:1234-7.
    PubMed     Text format     Abstract available
    
    
    
48. GRENHA V, Parada B, Ferreira C, Figueiredo A, et al
    Hepatitis B virus, hepatitis C virus, and kidney transplant acute rejection and survival.
    Transplant Proc. 2015;47:942-5.
    PubMed     Text format     Abstract available
    
    
    
49. MAGALHAES-COSTA P, Lebre L, Machado D, Chagas C, et al
    Lack of impact of hepatitis C virus infection on graft survival after kidney transplantation-a portuguese single-center experience.
    Transplant Proc. 2015;47:926-32.
    PubMed     Text format     Abstract available
    
    
    July 2014
50. DOS SANTOS AG, Guardia AC, Pereira TS, Ataide EC, et al
    Rhabdomyolysis as a Clinical Manifestation of Association With Ciprofibrate, Sirolimus, Cyclosporine, and Pegylated Interferon-alpha in Liver-Transplanted Patients: A Case Report and Literature Review.
    Transplant Proc. 2014;46:1887-8.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: